Verismo Therapeutics licenses in vivo CAR T engineering technology from Stanford Medicine, while Pfizer licenses in vivo ...
The White House has withdrawn Dr. Heidi Overton’s nomination for FDA commissioner just a day before a Senate committee vote.
Pharmaceutical Executive spoke with Ankit Jain, CEO and founder of Infinitus, about how agentic AI models are being deployed ...
Gilead signs royalty-free licensing agreements with three generic manufacturers to expand future access to its ...
Gilead signs royalty-free licensing deals to broaden Ebola antiviral access, FDA approves Cosentyx for polymyalgia rheumatica ...
Agentic AI turns wasted windshield time into productive CRM updates and deploys always-on virtual reps to support providers ...
New deals this week span across ophthalmology to Alzheimer’s, with three new acquisitions and one research collaboration.
FDA has approved Gazyva (obinutuzumab) for the treatment of adult patients with primary membranous nephropathy (pMN) at risk ...
FDA approves three new therapies, a wave of dealmaking led by Johnson & Johnson, Eli Lilly, AmyriAD Therapeutics, and Sanofi, ...
Secukinumab offers a new steroid-sparing option in polymyalgia rheumatica, a disease with frequent relapse and meaningful glucocorticoid-associated morbidity, particularly in older adults. Phase III ...
Moderna used its 2026 Analyst Day to outline an oncology-driven growth strategy anchored by intismeran and other cancer ...
Moderna lays out an oncology-driven growth plan at its 2026 Analyst Day, Pfizer and Blackstone sign a co-funding deal worth ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results